
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

